Clinical-anamnestic features and life quality of patients with nodular and diffuse adenomyosis
Open Access
- 16 October 2021
- journal article
- research article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 13,p. 68-76
Abstract
Introduction.Adenomyosis remains one of the significant challenges in modern gynecology and affects a large number of women of reproductive age. The clinical presentation of adenomyosis is variable, with severity of symptoms depending on the form of the disease. In case of the occurrence of severe pelvic pain, dysmenorrhea and dyspareunia, the disease disrupts social functions and leads to a decrease in the patient’s quality of life.Aim.To study clinical and anamnestic features and patient’s quality of life with diffuse and nodular forms of adenomyosis.Materials and methods.The study included 126 patients with various forms of adenomyosis (45 patients with nodular adenomyosis (NAM), 81 with stage III – IV DAM). The control group included 20 patients with tubo-peritoneal factor of infertility, without adenomyosis based on the ultrasound and hysteroscopy findings. All patients underwent a comprehensive examination, including general clinical, instrumental and laboratory tests. The study included a comparative analysis of the obtained data and determination of the clinical and anamnestic characteristics of the patients with stage III – IV DAM as compared with the patients with NAM. We also studied the quality of life of patients with NAM and DAM on the basis of a specialized questionnaire on the study of the quality of life of patients with endometriosis – Endometriosis Health Profile, ENR-5+6. Statistical analysis and data processing were conducted using Microsoft Excel (version 16), Statistica 10.0, StatPlus 7.3, GraphPad Prism 9 software. Data processing was performed in accordance with the guidelines for medical and biological research.Results and discussion.As compared with patients with nodular adenomyosis, the patients with stage III-IV diffuse adenomyosis are characterized by an older age (42.1 (4.6) and 34.6 (6.2) years, respectively; p Conclusions.Stage III-IV DAM is characterized by a more severe course and marked symptoms as compared with NAM, and significantly affects the patient’s quality of life.Keywords
This publication has 17 references indexed in Scilit:
- Development of a French version of the Endometriosis Health Profile 5 (EHP-5): cross-cultural adaptation and psychometric evaluationQuality of Life Research, 2016
- Expression of GRIM-19 in adenomyosis and its possible role in pathogenesisFertility and Sterility, 2016
- Radical Surgery for Endometriosis: Analysis of Quality of Life and Surgical ProcedureClinical Medicine Insights: Women's Health, 2016
- Is pale the way to go to understand adenomyosis?Fertility and Sterility, 2015
- Translation and validation of the Endometriosis Health Profile (EHP-5) in patients with laparoscopically diagnosed endometriosisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2015
- The clinical and morphological features of nodular and diffuse forms of adenomyosisRussian Journal of Human Reproduction, 2015
- Laparoscopic treatment of endometriosis and effects on quality of life: A retrospective study using the short form EHP-5 endometriosis specific questionnaireJournal of Obstetrics and Gynaecology, 2014
- Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: Results from a prospective multicentric study in ItalyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Development of an endometriosis quality-of-life instrument: The Endometriosis Health Profile-30Obstetrics & Gynecology, 2001
- Myometrial zonal differentiation and uterine junctional zone hyperplasia in the non-pregnant uterusHuman Reproduction Update, 1998